Journal article
EFFECT OF SINGLE-AGENT IBRUTINIB ON TUMOR DEBULKING AND REDUCTIONS IN TUMOR LYSIS SYNDROME (TLS) RISK IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
CS Tam, JC Byrd, S O'Brien, S Coutre, PM Barr, RR Furman, TJ Kipps, JA Burger, D Stevens, J Sharman, P Ghia, I Flinn, C Zhou, J Ninomoto, DF James, WG Wierda
Hematological Oncology | Wiley | Published : 2017
DOI: 10.1002/hon.2438_96